Literature DB >> 6952951

Combination chemotherapy for acute lymphocytic leukaemia in 25 adults.

E G de Vries, N H Mulder, B Houwen, H Haaxma-Reiche.   

Abstract

Twenty-five consecutive adult patients with acute lymphocytic leukaemia (ALL) all achieved complete remission, twenty-two with vincristine-prednisone, while thirteen patients also received daunorubicin (DNR). Three patients obtained remission only after treatment with cytosine arabinoside (Ara-C), 6 thioguanine (6-TG) and adriamycin (ADM). Despite central nervous system (CNS) prophylaxis by intraventricular infections via an Ommaya reservoir, 2/22 patients had a CNS relapse. The median remission duration of the whole group was 19 months. Four patients could stop therapy after 3 years. The median survival duration of all patients was 38 months. The quality of life of the patients during this chemotherapeutic regimen was good.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6952951     DOI: 10.1007/bf00320761

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  15 in total

Review 1.  Acute leukemia in adults.

Authors:  M E Beard; G H Fairley
Journal:  Semin Hematol       Date:  1974-01       Impact factor: 3.851

2.  Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris).

Authors:  C Jacquillat; M Weil; M F Gemon; G Auclerc; J P Loisel; J Delobel; G Flandrin; G Schaison; V Izrael; A Bussel; C Dresch; C Weisgerber; D Rain; J Tanzer; Y Najean; M Seligmann; M Boiron; J Bernard
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

3.  Antithrombin III deficiency during asparaginase therapy.

Authors:  E Vellenga; N H Mulder; H O Nieweg
Journal:  Lancet       Date:  1980-03-22       Impact factor: 79.321

4.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

5.  Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: a Southwest Oncology Group study.

Authors:  M T Shaw; S O Raab
Journal:  Med Pediatr Oncol       Date:  1977

6.  Combination chemotherapy for acute lymphoblastic leukaemia in adults.

Authors:  T A Lister; J M Whitehouse; M E Beard; R L Brearley; P F Wrigley; R T Oliver; J E Freeman; R K Woodruff; J S Malpas; A M Paxton; D Crowther
Journal:  Br Med J       Date:  1978-01-28

7.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

8.  Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973).

Authors:  R Willemze; H Hillen; C A Hartgrink-Groeneveld; C Haanen
Journal:  Blood       Date:  1975-12       Impact factor: 22.113

9.  Adult acute leukaemia.

Authors:  K Atkinson; D G Wells; H M Clink; H E Kay; R Powles; T J McElwain
Journal:  Br J Cancer       Date:  1974-09       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.